Omeros (OMER) Non-Current Deffered Revenue (2012 - 2018)

Omeros (OMER) reported Non-Current Deffered Revenue of $8.2 million for Q4 2018, down 6.21% on a YoY basis from $8.7 million in Q4 2017, and down 1.78% sequentially from $8.3 million in Q3 2018.

Omeros (OMER) Non-Current Deffered Revenue (2012 - 2018) Analysis & Trends

Omeros (OMER) has 7 years of Non-Current Deffered Revenue data on file, last reported at $8.2 million in Q4 2018.

  • For the quarter ending Q4 2018, Non-Current Deffered Revenue fell 6.21% year-over-year to $8.2 million; the trailing twelve-month figure through Dec 2018 stood at $8.2 million (down 6.21% YoY), and the FY2018 full-year result was $8.2 million, down 6.21% from the prior year.
  • Non-Current Deffered Revenue slipped to $8.2 million in Q4 2018, from $8.3 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $9.2 million in Q1 2016 to a low of $8.2 million in Q4 2018.
  • A 5-year average of $8.9 million and a median of $9.0 million in 2017 frame the typical range for Non-Current Deffered Revenue.
  • Across the five-year window, Non-Current Deffered Revenue jumped 122.99% in 2014 and retreated 6.21% in 2018, its largest moves.
  • Tracing OMER's Non-Current Deffered Revenue over 5 years: stood at $9.0 million in 2014, then rose by 1.73% to $9.2 million in 2015, then dropped by 0.71% to $9.1 million in 2016, then fell by 4.64% to $8.7 million in 2017, then dropped by 6.21% to $8.2 million in 2018.
  • Business Quant data shows OMER's Non-Current Deffered Revenue at $8.2 million in Q4 2018, $8.3 million in Q3 2018, and $8.5 million in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Omeros 739.31 Mn 739.31 Mn 9.31 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 8.18 Mn
Sep 30, 2018 8.33 Mn
Jun 30, 2018 8.45 Mn
Mar 31, 2018 8.58 Mn
Dec 31, 2017 8.72 Mn
Sep 30, 2017 8.84 Mn
Jun 30, 2017 8.94 Mn
Mar 31, 2017 9.04 Mn
Dec 31, 2016 9.14 Mn
Sep 30, 2016 9.19 Mn
Jun 30, 2016 9.21 Mn
Mar 31, 2016 9.22 Mn
Dec 31, 2015 9.21 Mn
Sep 30, 2015 9.17 Mn
Jun 30, 2015 9.13 Mn
Mar 31, 2015 9.09 Mn
Dec 31, 2014 9.05 Mn
Sep 30, 2014 8.94 Mn
Jun 30, 2014 8.67 Mn
Mar 31, 2014 8.41 Mn